Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3356 |
|
| Actual shortage: | 218 (6%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 3128 (93%) | |
Discontinuation Reports |
359 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 335 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
62 (26%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-HYDRALAZINE | 25MG | TABLET | Resolved | 2017-08-03 | 2017-10-10 | 18184 |
| APO-HYDRALAZINE | 50MG | TABLET | Resolved | 2017-08-03 | 2017-10-10 | 18187 |
| APO-HYDRALAZINE | 10MG | TABLET | Resolved | 2017-08-03 | 2017-10-10 | 18190 |
| APO-HYDRALAZINE | 25MG | TABLET TABLET | Resolved | 2024-01-19 | 2024-04-05 | 216650 |
| APO-HYDRALAZINE | 50MG | TABLET TABLET | Resolved | 2022-10-28 | 2023-01-06 | 172882 |
| APO-HYDRALAZINE | 25MG | TABLET TABLET | Resolved | 2022-11-11 | 2022-12-23 | 174332 |
| APO-HYDRALAZINE | 10MG | TABLET TABLET | Resolved | 2022-11-27 | 2022-12-23 | 175889 |
| APO-HYDRALAZINE | 25MG | TABLET TABLET | Resolved | 2021-05-25 | 2021-07-15 | 139842 |
| APO-HYDRALAZINE | 50MG | TABLET TABLET | Resolved | 2021-06-18 | 2021-07-15 | 141238 |
| APO-HYDRALAZINE | 25MG | TABLET TABLET | Resolved | 2023-09-22 | 2023-11-06 | 204999 |
| APO-HYDRALAZINE | 25MG | TABLET | Resolved | 2019-11-20 | 2019-11-25 | 99299 |
| APO-HYDRALAZINE | 50MG | TABLET | Resolved | 2019-11-20 | 2019-11-25 | 99304 |
| APO-HYDRALAZINE | 25MG | TABLET | Resolved | 2019-12-12 | 2020-01-07 | 101094 |
| APO-HYDRALAZINE | 50MG | TABLET | Resolved | 2020-01-29 | 2020-02-28 | 104694 |
| APO-HYDRALAZINE | 25MG | TABLET TABLET | Resolved | 2020-04-22 | 2020-05-20 | 112738 |
| APO-HYDRALAZINE | 50MG | TABLET TABLET | Resolved | 2025-01-09 | 2025-02-07 | 247379 |
| APO-HYDRALAZINE | 25MG | TABLET TABLET | Resolved | 2024-05-24 | 2024-06-14 | 228804 |
| APO-HYDRALAZINE | 25MG | TABLET TABLET | Resolved | 2024-06-27 | 2024-09-20 | 231481 |
| APO-HYDROCHLOROTHIAZIDE | 12.5MG | TABLET | Resolved | 2017-07-25 | 2017-09-15 | 16931 |
| APO-HYDROCHLOROTHIAZIDE | 12.5MG | TABLET | Resolved | 2018-12-12 | 2019-01-17 | 69302 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-TIMOP | 0.5% | SOLUTION | Discontinued | 2019-01-03 | 2019-01-03 | 70894 |
| APO-TIMOP GEL | Discontinued | 2019-01-03 | 2019-01-03 | 71020 | ||
| APO-TIMOP | Discontinued | 2019-01-02 | 2019-01-02 | 70818 | ||
| APO-TOLTERODINE | 1MG | TABLET | Discontinued | 2018-09-08 | 2019-01-17 | 60822 |
| APO-TOLTERODINE | 2MG | TABLET | Discontinued | 2018-09-08 | 2018-11-09 | 60825 |
| APO-TOLTERODINE | 2MG | TABLET | Discontinued | 2018-09-08 | 2019-06-12 | 60828 |
| APO-TRAZODONE TABLETS 100MG | 100MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60831 |
| APO-TRAZODONE TABLETS 50MG | 50MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60834 |
| APO-VALACYCLOVIR | 500MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60840 |
| APO-VALGANCICLOVIR | 450MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60843 |
| APO-VALPROIC ACID ORAL SOLUTION | 250MG | SOLUTION | Discontinued | 2023-09-26 | 2023-11-02 | 205310 |
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71029 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71032 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71035 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71038 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71044 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71048 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71051 | ||
| APO-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71054 |
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71057 |